A review conducted by Menghoum and Hermans who investigated clinical and biochemical characteristics of euglycemic DKA in patients with T2DM while on SGLT2i found that the average age at presentation was 57.6 ± 14.9 years, 48.6% were female, 52.8% were male, duration of DM was roughly 12.2 ± 9.9 years, average BMI was 27.6 ± 6.2 kg/m2, and euglycemic DKA occurred at different times of usage of SGLT2 inhibitors [21]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.